Literature DB >> 1016194

The influence of dihydroergotamine on adenosine-induced and reactive coronary vasodilation. Interaction of dihydroergotamine and coronary vasodilation.

G Raberger, W Schütz, M Zimpfer, O Kraupp.   

Abstract

The influence of dihydroergotamine on adenosine-induced and reactive vasodilation after long and short periods of coronary artery occlusion was investigated in thoracotomized dogs. Adenosine-induced vasodilation (intracoronary administration) and vasodilation after long periods of coronary artery occlusion (25-35 beats) were similarly influenced, i.e. decreased by the i.v. administration of 10 mug/kg dihydroergotamine. By contrast vasodilation after short periods of coronary artery occlusion (4-7 beats) tended to be increased. This difference in response is thought to arise from two distinct mechanisms of coronary vasodilation after coronary artery occlusion depending on the duration of the occlusion period. The vasodilation after short periods of coronary artery occlusion possibly corresponds to physiological autoregulation. With longer periods of coronary artery occlusion an additional, consecutive mechanism is called into action.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1016194     DOI: 10.1007/BF01906409

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  5 in total

1.  Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation.

Authors:  S Mellander; I Nordenfelt
Journal:  Clin Sci       Date:  1970-08       Impact factor: 6.124

2.  [Peripheral circulatory effects of ergotamine, dihyroergotamine and 1-methylergotamine on the innevated, perfused hindlimb of the o].

Authors:  W H Aellig
Journal:  Helv Physiol Pharmacol Acta       Date:  1967

3.  Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog.

Authors:  E Müller-Schweinitzer; E Stürmer
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

4.  Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal muscle.

Authors:  D Chu; E Stuermer; B Berde
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

5.  Effect of dihydroergotamine (DHG) on the capacitance, resistance and precapillary sphincter vessels of denervated cat skeletal muscle.

Authors:  D A Owen; E Stuermer
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

  5 in total
  3 in total

1.  The effects of nitroglycerin on exercise-induced regional myocardial contractile dysfunction are not diminished by pretreatment with dihydroergotamine.

Authors:  W Schneider; G Krumpl; N Mayer; G Raberger
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

2.  Coronary reactive hyperaemia and coronary dilator action of adenosine during intracoronary infusion of angiotensin II.

Authors:  M Zimpfer; W Schütz; T Benke; G Raberger
Journal:  Basic Res Cardiol       Date:  1979 May-Jun       Impact factor: 17.165

3.  Assessment of increasing intravenous adenosine dose in fractional flow reserve.

Authors:  David Sparv; Matthias Götberg; Jan Harnek; Tobias Persson; Bjarne Madsen Hardig; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2017-02-14       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.